HiberGene HiberGene Molecular SARS-CoV-2 Test Gets CE Mark With a €930,000 from Horizon 2020, the firm is conducting additional stories to evaluate other uses for the test, including using new specimen types and patient cohorts. Diagnostics Firms Rush to Develop Rapid Point-of-Care Tests for Novel Coronavirus Premium A handful of rapid 2019-nCoV assays are in the works which could help triage patients more effectively and avoid unnecessary quarantines. HiberGene Outlines Plans for Low-Cost Point-of-Care Molecular Diagnostic System Premium The Dublin, Ireland-based company plans to launch its new instrument by the end of 2021 and will pursue CLIA waiver in the US. HiberGene Gets CE Mark for Rapid Flu Combo MDx The firm’s test for detecting flu and differentiating between subtypes A and B is being launched in Europe, Asia, and South America. HiberGene to Launch Three Multiplex Infectious Disease Tests by Year End; Seeks US Partner Premium The Dublin-based company also aims to raise up to €5 million this year to support additions to its R&D and sales and marketing teams. Oct 3, 2017 HiberGene Meningitis Test Gets CE Mark Apr 12, 2017 Hibergene Closes €6.7M Series B Funding Round Dec 15, 2016 HiberGene Launches CE-Marked C. Diff Test Oct 18, 2016 HiberGene Receives CE Mark for Group B Strep Test Breaking News Analysis Finds Sibling Cascade Testing Could Be Cost Effective in Pediatric Cancer Armonica Technologies Closes $2M Series B Financing Round Top Five Articles on GenomeWeb Last Week: SARS-CoV-2 PCR Tests; California Cancer Testing Law; More In Brief This Week: The Jackson Laboratory, CareDx, Merck Global Health Innovation Fund, and More People in the News: New Appointments at Grail, Foundation Medicine, Personalis, More New Products Posted to GenomeWeb: NanoString, Sophia Genetics, EliTech, Lybe Scientific, More The Scan J&J Booster Support A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times. To Keep the Cases Moving The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases. NAS Expels Archaeologist Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences. PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.